Diality Raises $12.5M for its Portable Home HD System
Expected to be flexible, easy to use, and portable, the pipeline Diality machine has obtained development support in a Series B investment round. CEO Osman Khawar pointed to rising costs and poor outcomes for in-center HD the COVID-19 pandemic as factors driving a push for home treatments.
Read the full article » | Posted 11-12-2020
Related Articles
- VenoStent, Inc. is Recruiting Patients for a Clinical Trial of the SelfWrap Posted 10-14-2025
- Diality Treated its First Patient in the Moda-flx Home IDE PRESCRIBE Cinical Trial Posted 10-14-2025
- eGenesis Announces IND Clearance for EGEN-2784 in Kidney Transplant Posted 09-15-2025
- The First Artificial Kidney Built in Canada has Ties to London: A Revolution in Care for Patients with Kidney Failure Posted 09-15-2025

